Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.
ROCKVILLE, Md., Oct. 8, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, today announced that its European patent EP3722434, protecting EpyQ®, the company's ...
Under a strategic collaboration between Wacker and Gearbox Biosciences, both the companies will work together to accelerate the development of next-generation plasmid DNA (a critical raw material for ...
Wacker Chemie AG (Munich, Germany)’s has combined expertise in GMP manufacturing of biologics, including pDNA, with Gearbox Bioscience’s innovative solutions for antibiotic-free plasmid proliferation ...
Last week, WACKER Chemie AG announced its collaboration with Gearbox Biosciences to produce plasmid DNA (pDNA), a key starting ingredient for mRNA vaccines and cell and gene therapies (CGTs). The ...
IMUNON announces promising Phase 1 results for IMNN-101, a DNA plasmid vaccine demonstrating enhanced durability and potential advantages over mRNA vaccines. Phase 1 clinical trial results of IMNN-101 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback